title: Features and outcome of galactokinase deficiency in children diagnosed by newborn screening.
abstract: Galactokinase deficiency (GALK-D), an autosomal recessive disorder in the Leloir pathway, results in accumulation of galactose, galactitol, and galactonate and leads to early onset of juvenile bilateral cataract. Highest incidence of GALK-D is found in Romani populations. The migration wave due to the Yugoslavian civil war has changed the spectrum of inborn errors of metabolism within Europe. Hence, newborn screening (NBS) in the Berlin region, performed from 1991 until 2010 in 683,675 neonates, revealed an increased incidence of GALK-D of 1:40,000, comparable to that of galactose-1-phosphate-uridyltransferase deficiency. A total of 44% of GALK-D patients were of Romani origin. All patients of Bosnian or Serbian origin were homozygous for the Romani founder mutation p.P28T. Detection of GALK-D by NBS and early start of galactose-restricted diet resulted in regression or prevention of cataracts. Slight cataracts without visual impairment occurred in 50% of the patients, 56% of whom were noncompliant. Further clinical symptoms, e.g., hypoglycemia, mental retardation, microcephaly, and failure to thrive, were associated with noncompliance. With treatment, galactose in blood decreased from 8,892 ± 5,243 to 36.5 ± 49.3 μmol/l, galactose in urine from 31,820 ± 32,103 to 30.0 ± 36.1 μmol/mmol creatinine, galactitol in RBC from 1,584 ± 584 to 12.3 ± 9.4 μmol/l, and galactitol in urine from 11,724 ± 4,496 to 236 ± 116 μmol/mmol creatinine. This is the first presentation of outcome and clinical features in GALK-D patients diagnosed by NBS. As our data suggest, GALK-D should be considered for inclusion in NBS in populations expected to have substantial numbers of GALK-D carriers, e.g., Yugoslavian immigrants.
authors.affiliation: Department of Pediatrics, Charité Universitätsmedizin Berlin, Berlin, Germany. julia.hennermann@charite.de
authors.forename: Julia B
authors.initials: JB
authors.lastname: Hennermann
authors.forename: Peter
authors.initials: P
authors.lastname: Schadewaldt
authors.forename: Barbara
authors.initials: B
authors.lastname: Vetter
authors.forename: Yoon S
authors.initials: YS
authors.lastname: Shin
authors.forename: Eberhard
authors.initials: E
authors.lastname: Mönch
authors.forename: Jeannette
authors.initials: J
authors.lastname: Klein
mesh_terms: D017522:Bosnia and Herzegovina; D004641:Emigration and Immigration; D005260:Female; D004376:Galactitol / Q000378:metabolism; D005690:Galactose / Q000378:metabolism; D005693:Galactosemias / Q000175:diagnosis / Q000208:ethnology / Q000628:therapy; D005858:Germany; D006720:Homozygote; D006801:Humans; D015994:Incidence; D007231:Infant, Newborn; D008297:Male; D009154:Mutation; D015997:Neonatal Screening / Q000379:methods; D055771:Serbia; D016896:Treatment Outcome
chemical_list: D004376:Galactitol; D005690:Galactose